Literature DB >> 21263114

A critical role of interleukin-10 in modulating hypoxia-induced preeclampsia-like disease in mice.

Zhongbin Lai1, Satyan Kalkunte, Surendra Sharma.   

Abstract

Hypoxia has been implicated in the pathogenesis of preeclampsia, a hypertensive disorder of pregnancy. However, in vivo evidence and mechanistic understanding remain elusive. Preeclampsia is associated with impaired placental angiogenesis. We have recently shown that interleukin (IL)-10 can support trophoblast-driven endovascular crosstalk. Accordingly, we hypothesize that pathological levels of oxygen coupled with IL-10 deficiency induce severe preeclampsia-like features coupled with elevated production of antiangiogenic factors, apoptotic pathways, and placental injury. Exposure of pregnant wild-type and IL-10(-/-) mice to 9.5% oxygen resulted in graded placental injury and systemic symptoms of renal pathology, proteinuria (wild-type 645.15 ± 115.73 versus 198.09 ± 93.45; IL-10(-/-) 819.31 ± 127.85 versus 221.45 ± 82.73 μg/mg/24 hours) and hypertension (wild-type 118.37 ± 14.45 versus 78.67 ± 14.07; IL-10(-/-) 136.03 ± 22.59 versus 83.97 ± 18.25 mm Hg). Recombinant IL-10 reversed hypoxia-induced features in pregnant IL-10(-/-) mice confirming the protective role of IL-10 in preeclampsia. Hypoxic exposure caused marked elevation of soluble fms-like tyrosine kinase 1 (110.8 ± 20.1 versus 44.7 ± 11.9 ng/mL) in IL-10(-/-) mice compared with their wild-type counterparts (81.6 ± 13.1 versus 41.2 ± 8.9 ng/mL), whereas soluble endoglin was induced to similar levels in both strains (approximately 380 ± 50 versus 180 ± 31 ng/mL). Hypoxia-induced elevation of p53 was associated with marked induction of proapoptotic protein Bax, downregulation of Bcl-2, and trophoblast-specific apoptosis in utero-placental tissue. Collectively, we conclude that severe preeclampsia pathology could be triggered under certain threshold oxygen levels coupled with intrinsic IL-10 deficiency, which lead to excessive activation of antiangiogenic and apoptotic pathways.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21263114      PMCID: PMC3621110          DOI: 10.1161/HYPERTENSIONAHA.110.163329

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  53 in total

1.  TLR9 activation coupled to IL-10 deficiency induces adverse pregnancy outcomes.

Authors:  Jessica E Thaxton; Roberto Romero; Surendra Sharma
Journal:  J Immunol       Date:  2009-06-26       Impact factor: 5.422

2.  Preeclampsia is associated with abnormal expression of adhesion molecules by invasive cytotrophoblasts.

Authors:  Y Zhou; C H Damsky; K Chiu; J M Roberts; S J Fisher
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

3.  Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome?

Authors:  Y Zhou; C H Damsky; S J Fisher
Journal:  J Clin Invest       Date:  1997-05-01       Impact factor: 14.808

4.  Increased depth of trophoblast invasion after chronic constriction of the lower aorta in rhesus monkeys.

Authors:  Y Zhou; K Chiu; R J Brescia; C A Combs; M A Katz; J L Kitzmiller; D C Heilbron; S J Fisher
Journal:  Am J Obstet Gynecol       Date:  1993-07       Impact factor: 8.661

5.  Oxygen measurements in endometrial and trophoblastic tissues during early pregnancy.

Authors:  F Rodesch; P Simon; C Donner; E Jauniaux
Journal:  Obstet Gynecol       Date:  1992-08       Impact factor: 7.661

6.  A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies.

Authors:  J W Meekins; R Pijnenborg; M Hanssens; I R McFadyen; A van Asshe
Journal:  Br J Obstet Gynaecol       Date:  1994-08

7.  Hypoxia alters early gestation human cytotrophoblast differentiation/invasion in vitro and models the placental defects that occur in preeclampsia.

Authors:  O Genbacev; R Joslin; C H Damsky; B M Polliotti; S J Fisher
Journal:  J Clin Invest       Date:  1996-01-15       Impact factor: 14.808

8.  Pre-eclampsia is associated with an excess of proliferative immature intermediate trophoblast.

Authors:  R W Redline; P Patterson
Journal:  Hum Pathol       Date:  1995-06       Impact factor: 3.466

Review 9.  Interleukin-10: a multi-faceted agent of pregnancy.

Authors:  Jessica E Thaxton; Surendra Sharma
Journal:  Am J Reprod Immunol       Date:  2010-02-16       Impact factor: 3.886

10.  Oxygen dependence of cellular uptake of EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)a cet amide] : analysis of drug adducts by fluorescent antibodies vs bound radioactivity.

Authors:  C J Koch; S M Evans; E M Lord
Journal:  Br J Cancer       Date:  1995-10       Impact factor: 7.640

View more
  62 in total

Review 1.  Adaptive mechanisms controlling uterine spiral artery remodeling during the establishment of pregnancy.

Authors:  Michael J Soares; Damayanti Chakraborty; Kaiyu Kubota; Stephen J Renaud; M A Karim Rumi
Journal:  Int J Dev Biol       Date:  2014       Impact factor: 2.203

Review 2.  Uterine Regulatory T cells, IL-10 and hypertension.

Authors:  Tania Nevers; Satyan Kalkunte; Surendra Sharma
Journal:  Am J Reprod Immunol       Date:  2011-07       Impact factor: 3.886

3.  IL-10 supplementation increases Tregs and decreases hypertension in the RUPP rat model of preeclampsia.

Authors:  Ashlyn Harmon; Denise Cornelius; Lorena Amaral; Adrienne Paige; Florian Herse; Tarek Ibrahim; Gerd Wallukat; Jessica Faulkner; Janae Moseley; Ralf Dechend; Babbette LaMarca
Journal:  Hypertens Pregnancy       Date:  2015-05-21       Impact factor: 2.108

4.  In-vitro validation of cytokine neutralizing antibodies by testing with ovine mononuclear splenocytes.

Authors:  X Chen; S W Threlkeld; E E Cummings; G B Sadowska; Y-P Lim; J F Padbury; S Sharma; B S Stonestreet
Journal:  J Comp Pathol       Date:  2012-07-20       Impact factor: 1.311

Review 5.  Interleukin-10: a pleiotropic regulator in pregnancy.

Authors:  Shi-Bin Cheng; Surendra Sharma
Journal:  Am J Reprod Immunol       Date:  2014-10-01       Impact factor: 3.886

6.  Integrated Systems Biology Approach Identifies Novel Maternal and Placental Pathways of Preeclampsia.

Authors:  Nandor Gabor Than; Roberto Romero; Adi Laurentiu Tarca; Katalin Adrienna Kekesi; Yi Xu; Zhonghui Xu; Kata Juhasz; Gaurav Bhatti; Ron Joshua Leavitt; Zsolt Gelencser; Janos Palhalmi; Tzu Hung Chung; Balazs Andras Gyorffy; Laszlo Orosz; Amanda Demeter; Anett Szecsi; Eva Hunyadi-Gulyas; Zsuzsanna Darula; Attila Simor; Katalin Eder; Szilvia Szabo; Vanessa Topping; Haidy El-Azzamy; Christopher LaJeunesse; Andrea Balogh; Gabor Szalai; Susan Land; Olga Torok; Zhong Dong; Ilona Kovalszky; Andras Falus; Hamutal Meiri; Sorin Draghici; Sonia S Hassan; Tinnakorn Chaiworapongsa; Manuel Krispin; Martin Knöfler; Offer Erez; Graham J Burton; Chong Jai Kim; Gabor Juhasz; Zoltan Papp
Journal:  Front Immunol       Date:  2018-08-08       Impact factor: 7.561

Review 7.  Preeclampsia and health risks later in life: an immunological link.

Authors:  Shi-Bin Cheng; Surendra Sharma
Journal:  Semin Immunopathol       Date:  2016-06-23       Impact factor: 9.623

8.  Genome-wide associated loci influencing interleukin (IL)-10, IL-1Ra, and IL-6 levels in African Americans.

Authors:  Fasil Tekola Ayele; Ayo Doumatey; Hanxia Huang; Jie Zhou; Bashira Charles; Michael Erdos; Jokotade Adeleye; Williams Balogun; Olufemi Fasanmade; Thomas Johnson; Johnnie Oli; Godfrey Okafor; Albert Amoah; Benjamin A Eghan; Kofi Agyenim-Boateng; Joseph Acheampong; Clement A Adebamowo; Alan Herbert; Norman Gerry; Michael Christman; Guanjie Chen; Daniel Shriner; Adebowale Adeyemo; Charles N Rotimi
Journal:  Immunogenetics       Date:  2011-12-29       Impact factor: 2.846

Review 9.  Inflammation, immunity, and hypertensive end-organ damage.

Authors:  William G McMaster; Annet Kirabo; Meena S Madhur; David G Harrison
Journal:  Circ Res       Date:  2015-03-13       Impact factor: 17.367

10.  The decidua of preeclamptic-like BPH/5 mice exhibits an exaggerated inflammatory response during early pregnancy.

Authors:  C Y Heyward; J L Sones; H E Lob; L C Yuen; K E Abbott; W Huang; Z R Begun; S D Butler; A August; C A Leifer; R L Davisson
Journal:  J Reprod Immunol       Date:  2017-04-10       Impact factor: 4.054

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.